IDA/ Hemophilia/ Thalassemia/ G6PD deficiency/ neuroblastoma Flashcards

1
Q

G6PD deficiency is a disease involving enzymes of the hexose monophosphate pathway.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

It has 3 clinical syndromes episodic hemolytic anemia, autoimmune hemolytic anemia and chronic non-spherocytic hemolytic anemia.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The most common manifestations are pallor and episodic acute hemolytic anemia.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The normal enzyme found in most populations is designated G6PD B+

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

For episodic or induced hemolytic anemia, reduced GSH provides protection against oxidant threats from certain drugs and infections that would otherwise cause precipitation of hemoglobin (Heinz bodies) or damage the RBC membrane.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Synthesis of RBC G6PD is determined by a gene on the X chromosome.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Heterozygous females have intermediate enzymatic activity and have 2 populations of RBC: one is normal and the other is deficient in G6PD activity.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Heterozygous females have many susceptible cells, hence, they have evident clinical hemolysis after exposure to oxidant drugs.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Episodic hemolytic anemia occurs more frequently in males than in females.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most individuals with G6PD deficiency are asymptomatic with no clinical manifestations of illness unless triggered by infection, drugs or ingestion of fava beans.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The degree of hemolysis varies with the inciting agent, amount ingested and severity of the enzyme deficiency.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

G6PD deficiency cannot produce hemolysis in the neonatal period.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Heinz bodies are visible on Wright stained blood film and seen within 7 days.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The diagnosis of G6PD by direct measurement is that enzyme activity in affected persons is ≤ 10% of normal.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

After a hemolytic episode reticulocytes and young RBC predominant so testing can be done now.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diagnosis can be suspected when G6PD activity is within the low normal range in the presence of a high reticulocyte count.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

G6PD deficiency should not be considered in any neonatal patients with hyperbilirubinemia and borderline low G6PD activity.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prevention of hemolysis constitutes the most important therapeutic measure.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The usual doses of aspirin and trimethoprim-sulfamethoxazole cause clinically relevant hemolysis in the A - variety.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

If severe hemolysis has occurred, supportive therapy may require blood transfusion although recovery is the rule when the oxidant agent is discontinued.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Neuroblastoma is the most common extracranial solid tumor in children and the most commonly diagnosed malignancy in infants.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Neuroblastoma tumors for a spectrum from tumors in the primarily undifferentiated small round cells (neuroblastoma) to tumors consisting of mature and maturing Schwannian stroma.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The tumors may resemble other small round blue cell tumors such as rhabdomyosarcoma, Ewing’s Sarcoma and Osteosarcoma.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Genetic characteristics of neuroblastoma tumors that are of prognostic importance include amplification of the MYCN (N-myc) protooncogene and tumor cell DNA content or ploidy.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Neuroblastoma develops only at one site of sympathetic nervous system tissue.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

The signs and symptoms of neuroblastoma mimics many other disorders hence early diagnosis.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Neuroblastoma originating in the superior cervical ganglion can result in Horner Syndrome.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Stage 4s has an incidence of 5% and survival at 5 yrs is <80%.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Neuroblastoma can be diagnoses without a primary tumor biopsy if small round blue tumor cells are observed in bone marrow samples.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Tumor markers homovanillic acid and vanillylmandelic acid are elevated in the blood of approximately 95% of cases and help to confirm the diagnosis.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

INSS stage 4s refer to neuroblastoma in children younger than 1 year of age with discrimination to liver, skin and/or bone marrow without bone involvement and with a primary tumor that would otherwise be staged as INSS stage 1 or 2.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

The usual treatment for children with low risk neuroblastoma is surgery for stage 1 or 2.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

The treatment for stage 4s with cure rates generally >90% without further therapy.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Stage 4s neuroblastoma have an unfavorable prognosis and do not regress spontaneously without therapy.

A

false

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Children with intermediate risk neuroblastoma including children with stage 3 disease and infants with stage 4 disease and favorable characteristics have an excellent prognosis and >90% survival with moderate treatment.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Hemophilia A and Hemophilia B are the most common and serious congenital coagulation factor deficiencies and their clinical findings are virtually identical.

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Increased levels of the contact factors (Factor XII, HMWK and prekallikrein) are associated with significant prolongation of aPTT.

A

false

38
Q

In the laboratory, prothrombin time (PT) measures the activation of factor X by factor VII and is therefore normal in patients with factor VIII or factor IX deficiency.

A

true

39
Q

In hemophilia A or B, clot formation is delayed and is not robust because inadequate thrombin generation leads to failure to form a tightly cross-linked fibrin clot to support the platelet plug, hence the patients with hemophilia slowly form a soft friable clot.

A

true

40
Q

Hemophilia has a high rate of spontaneous mutation

A

true

41
Q

The obvious symptoms such as easy bruising, intramuscular hematomas and hemarthrosis begins when the child begins to sit-up.

A

false

42
Q

The hallmark of hemophilia bleeding is hemathrosis and many are spontaneous.

A

true

43
Q

Life threatening bleeding in hemophilia is caused by bleeding into vital structures like the CNS or by exsanguination.

A

true

44
Q

If head trauma is of sufficient concern to suggest radiologic evaluation, factor replacement should be given. Simply put “image first, treat second”.

A

false

45
Q

The screening test for hemophilia is PTT and it is usually 2-3x the upper limit of normal.

A

true

46
Q

Hemophilia occurs in approximately 1:5000 males with 85% having factor VIII deficiency and 10-15% factor IX deficiency.

A

true

47
Q

With the availability of recombinant replacement products, prophylaxis is the standard of care for most children with severe hemophilia.

A

true

48
Q

The complications of hemophilia are chronic arthropathy, development of an inhibitor to either factor 8 or 9 and the risk of transfusion transmitted infectious diseases.

A

true

49
Q

Hemophilia C, reduced level of factor XI has mild to moderate bleeding symptoms.

A

true

50
Q

The bleeding associated with factor XI deficiency is not correlated with the amount of factor XI and if with bleeding, FFP is given.

A

true

51
Q

A full term newborn infant has 0.5 g of iron, compared to 5 g of iron in adults.

A

true

52
Q

During infancy, when growth is slow, the 1 mg/L of iron in cow’ and breastmilk makes it difficult to maintain body iron.

A

false

53
Q

Breastfed infants have an advantage because they absorb iron 2-3 times more efficiently than infants fed cow’s milk.

A

true

54
Q

Delayed (1-3min) clamping of the umbilical cord can improve iron status and reduce the risk of iron deficiency whereas early clamping (<30sec) puts the infant at risk for iron deficiency.

A

true

55
Q

In term infants, anemia caused solely by inadequate dietary iron usually occurs at 9-24 months of age and is relatively uncommon thereafter.

A

true

56
Q

Pallor is the most important clinical sign of iron deficiency and it is visible when the hemoglobin falls to 9-10 g/dL.

A

false

57
Q

In mild to moderate iron deficiency (Hgb 6-10g/dL), compensatory mechanisms (Inc levels of 2-3 diphosphoglycerate and a shift of oxygen dissociation curve) may be so effective that few symptoms of anemia aside from mild irritability are noted.

A

true

58
Q

Nonhematologic consequences of iron deficiency include pica and pagophagia.

A

true

59
Q

In progressive iron deficiency, a sequence of biochemical and hematologic events occur. First, tissue iron stores are depleted reflected by reduced serum ferritin, as iron storage protein which provides an estimate of body iron stores.

A

true

60
Q

Next, serum iron levels increase, the iron-binding capacity of the serum (serum transferrin) decreases and the transferrin saturation falls below normal.

A

false

61
Q

As iron stores decreases, iron becomes unavailable to complex with protoporphyrin to form heme, free erythrocyte protoporphyrin accumulate and hemoglobin synthesis is impaired.

A

true

62
Q

The hemoglobin is decreased in iron deficiency anemia, alpha or beta thalassemia and anemia of chronic disease.

A

true

63
Q

The serum ferritin is decreased in iron deficiency anemia, thalassemia and anemia of chronic disease.

A

false

64
Q

A daily total dose of 3-6mg/kg of elemental iron in 3 divided doses is adequate for treatment.

A

true

65
Q

Iron medication should be continued for 2-3 months after blood values normalizes to reestablish iron stores.

A

true

66
Q

Beta Thalassemia syndromes result from a decrease in beta-globin chains which results in a relative excess of alpha-globin chains.

A

true

67
Q

Beta-Thalassemia refers to the absence of production of the beta-globin.

A

true

68
Q

Beta-thalassemia indicates a mutation that makes a decreased amount of normal beta-globin, but it is still present (HbA).

A

true

69
Q

In alpha-thalassemia, an alpha mutation indicates no alpha chains produced from that gene

A

true

70
Q

An alpha mutation produces a decreased amount of alpha globin chain.

A

true

71
Q

For the pathophysiology of Beta thalassemia major there is inadequate beta globin gene production leading to a decreased levels of abnormal hemoglobin (HbA) and unbalanced alpha and beta globin chain production.

A

false

72
Q

In Alpha-thalassemia, beta and gamma globin chains are produced in excess which form bast hemoglobin (Y4) in fetal life and HbH (B4) after birth and are nonfunctional hemoglobins with very high oxygen affinity.

A

true

73
Q

If intreated, a child with homozygous Bo thalassemia becomes symptomatic during the 2nd - 6mo of llife.

A

true

74
Q

The signs of ineffective erythropoiesis are growth failure, bone deformities and no organ enlargement.

A

false

75
Q

A child with thalassemia fascie, pathologic bone fracture, marked hepatosplenomegaly and cachexia is a classic presentation of moderate disease.

A

false

76
Q

Chronic transfusion therapy improves the quality of life and reduces the complications of severe thalassemia.

A

true

77
Q

Each mL of packed RBC contains 1 mg of iron and physiologically there is a mechanism to eliminate excess body iron.

A

false

78
Q

In severe beta-thalassemia the laboratory findings are microcytosis (MCV), hypochromia, target cells and reticulocytopenia.

A

true

79
Q

Even if a child does not receive transfusions, iron eventually accumulate with elevated serum ferritin and transferrin saturation.

A

true

80
Q

Early definitive diagnosis is recommended and newborn screening techniques such as hemoglobin electrophoresis is definitive.

A

false

81
Q

Transfusions should generally be given at intervals of 3-4 weeks with the goal of being able to maintain a pretransfusion hemoglobin level of 9.5-10.5 g/dL.

A

true

82
Q

Serial serum ferritin levels are a useful screening technique in assessing iron balance trends but results may not accurately predict quantitative iron stores.

A

true

83
Q

Iron chelation therapy should start as soon as the patient becomes significantly iron overloaded and this occurs after 1 year of transfusion therapy and correlates with the serum ferritin of <1000ng/mL and or a liver iron concentration of >2,500ng/g dry weight.

A

false

84
Q

Splenectomy may be required in thalassemia patients who develop hypersplenism that is a falling steady state hemoglobin and or a rising transfusion requirement.

A

true

85
Q

Iron chelation therapy is started for patients with significant iron overload.

A

true

86
Q

Thalassemia trait is often misdiagnosed as iron deficiency in children because the 2 produce similar hematologic abnormalities on CBC and iron deficiency is much more prevalent.

A

true

87
Q

For alpha thalassemia syndrome, the deletion of all 4 alpha globin gene alleles causes prfound anemia during fetal life resulting in hydrops fetalis.

A

true

88
Q

Alpha thalassemia trait, a deletion of 2 alpha globin genes alleles manifest as a microcytic anemia that can be mistaken for iron deficiency anemia.

A

true

89
Q

HbH is a deletion of 3 alpha globin gene alleles.

A

true

90
Q

Patients with HbH disease have a marked microcytosis, anemia, mild splenomegaly and occassionaly scleral icterus or cholelithiasis.

A

true